Cyclic carbamates and isoxazolidines as IIb/IIIa antagonists
STR1 This invention relates generally to cyclic carbamates and hydroxylamines which are useful as antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex, to pharmaceutical compositions containing such compounds, processes for prepar